Cargando…

Clinical Evaluation and Cost-Effectiveness Analysis of Serum Tumor Markers in Lung Cancer

The detection of serum tumor markers is valuable for the early diagnosis of lung cancer. Tumor markers are frequently used for the management of cancer patients. However, single markers are less efficient but marker combinations increase the cost, which is troublesome for clinics. To find an optimal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rong, Wang, Guoqing, Zhang, Nan, Li, Xue, Liu, Yunde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792518/ https://www.ncbi.nlm.nih.gov/pubmed/24167812 http://dx.doi.org/10.1155/2013/195692

Ejemplares similares

Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
por: Jiang, Rifeng, et al.
Publicado: (2017)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

The Predictive Efficacy of Tumor Mutation Burden (TMB) on Nonsmall Cell Lung Cancer Treated by Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Nan, Zhang, et al.
Publicado: (2021)

Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer
por: Wang, Jiasi, et al.
Publicado: (2020)

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
por: Abbas, Muhammad, et al.
Publicado: (2020)

Clinical value evaluation of serum markers for early diagnosis of colorectal cancer
por: Song, Wen-Yue, et al.
Publicado: (2020)

Are Ureaplasma spp. a Cause of Nongonococcal Urethritis? A Systematic Review and Meta-Analysis
por: Zhang, Nan, et al.
Publicado: (2014)

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.
por: Pujol, J. L., et al.
Publicado: (1993)

Serum biochemical markers in lung cancer.
por: Burt, R. W., et al.
Publicado: (1978)

Serum exosomal proteomics analysis of lung adenocarcinoma to discover new tumor markers
por: Liu, Shanshan, et al.
Publicado: (2022)

The evaluation of prognostic value of serum tumor marker in ovarian tumors
por: Sharief, S, et al.
Publicado: (2015)

The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
por: Jiang, Chunyang, et al.
Publicado: (2022)

Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer
por: Sun, Mingzhong, et al.
Publicado: (2016)

Construction and Validation of a Lung Cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers
por: Kang, Chunyan, et al.
Publicado: (2021)

Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer
por: Mehta, Anurag, et al.
Publicado: (2021)

Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma
por: Zhi, Qiongjie, et al.
Publicado: (2016)

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
por: Dai, Nan, et al.
Publicado: (2013)

Effect Evaluation of Bronchial Artery Embolization for Hemoptysis of Lung Cancer and Changes in Serum Tumor Markers and miR-34 Levels
por: Huang, Yan, et al.
Publicado: (2022)

Prognostic evaluation of preoperative serum tumor marker‐negative cases in non‐small cell lung cancer: A retrospective study
por: Onuki, Yuichiro, et al.
Publicado: (2022)

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
por: Li, Yang, et al.
Publicado: (2019)

Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?
por: Bastawisy, Ahmed El, et al.
Publicado: (2014)

Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study
por: Shi, Wen-Qing, et al.
Publicado: (2020)

The utilization pattern of serum tumor markers in lung cancer patients: A population‐based retrospective descriptive study
por: Wang, Hongchun, et al.
Publicado: (2020)

Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

Retracted: Effect Evaluation of Bronchial Artery Embolization for Hemoptysis of Lung Cancer and Changes in Serum Tumor Markers and miR-34 Levels
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies
por: Biaoxue, Rong, et al.
Publicado: (2016)

Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer Patients
por: Wang, Xu, et al.
Publicado: (2017)

Preoperative Serum Tumor Marker Levels in Gastric Cancer
por: Polat, Erdal, et al.
Publicado: (2014)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2019)

Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer
por: Guo, Wei, et al.
Publicado: (2014)

Clinical Associations of Preoperative and Postoperative Serum CEA and Lung Cancer Outcome
por: Jiao, Zonglin, et al.
Publicado: (2021)

Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
por: Sun, Zhiwei, et al.
Publicado: (2019)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer
por: Jiang, Richeng, et al.
Publicado: (2016)

Metabolic phenotypes, serum tumor markers, and histopathological subtypes in predicting bone metastasis: analysis of 695 patients with lung cancer in China
por: Jiang, Maoqing, et al.
Publicado: (2023)

Proteomics Analysis for Finding Serum Markers of Ovarian Cancer
por: Cheng, Yushan, et al.
Publicado: (2014)

Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer
por: Su, Jianli, et al.
Publicado: (2022)

Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease
por: Bao, Yunqi, et al.
Publicado: (2021)

The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer
por: Lv, Xing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1kovks40vsvkd1edg2dvn9jq4p